BUY Eternal Limited — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))12 Aug 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
4 advisors have active short-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · adjacent horizon·20 Aug · today
7 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·21 Aug · today
Q1 Earnings: ICICI Bank, Eternal, Titan Included In Morgan Stanley's Eight Bottom-Up Picks — Check Full List, Target Prices
NewsNdtv-Profit·20 Aug · yesterday
Eternal, Paytm make it to Bernstein's India portfolio; Check out the stock excluded
NewsCnbc-Tv18·19 Aug · 2d ago
Elara Capital raises Eternal allocation to 85-90%, says avoid Swiggy for now
NewsCnbc-Tv18·13 Aug · 1w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Eternal
- BUY — Kush Bohra23 Oct 2026 · ~2 weeks · target ₹330 · Active
- BUY — Siddharth Khemka, Motilal Oswal23 Oct 2026 · ~1 year · target ₹420 · Active
- BUY — Arun Kumar Mantri23 Oct 2026 · ~2 weeks · target ₹325 · Active
- BUY — IDBI Capital23 Oct 2026 · ~2 weeks · target ₹322 · Active
- BUY — Shivangi Sarda, Motilal Oswal23 Oct 2026 · ~1 year · target ₹325 · Active
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

